Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/8/2019
SIETES contiene 92797 citas

 1 a 20 de 31 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Sultana J, Moretti U, Addis A, Caduff P, Capuano A, Kant A, Laporte JR, Lindquist M, Raine J, Sartori D, Trifirò G, Tuccori M, Venegoni M, van Puijenbroek E, Leone R. Workshop on the Italian pharmacovigilance system in the international context: critical issues and perspectives. Drug Saf 2019;42:mayo. [Ref.ID 103115]
Edwards IR, Lindquist M. Social media and networks in pharmacovigilance: boon or bane?. Drug Saf 2011;34:267-71. [Ref.ID 90433]
3. Cita con resumen
Caster O, Edwards IR, Norén GN, Lindquist M. Earlier discovery of pregabalin's dependence potential might have been possible. Eur J Clin Pharmacol 2011;67:319-20. [Ref.ID 90103]
4. Cita con resumen
Derijks H, Meyboom RHB, Heerdink ER, De Koning FHP, Janknegt R, Lindquist M, Egberts ACG. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol 2008;64:531-8. [Ref.ID 82990]
Lindquist M. The need for definitions in pharmacovigilance. Drug Saf 2007;30:825-30. [Ref.ID 81223]
Stahl M, Lindquist M, Edwards IR, Brown EG. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database. Pharmacoepidemiol Drug Saf 2004;13:355-63. [Ref.ID 70402]
7.Tiene citas relacionadas
Bate A, Edwards RI, Lindquist M, Orre R. Violation of homogeneity: a methodologic issue in the use of data mining tools. The authors' reply. Drug Saf 2003;26:364-6. [Ref.ID 65881]
Bate A, Lindquist M, Orre R, Edwards LR, Meyoboom RHB. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. Eur J Clin Pharmacol 2002;58:483-90. [Ref.ID 63693]
Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf 2002;25:393-7. [Ref.ID 62245]
11. Cita con resumen
van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002;11:3-10. [Ref.ID 61313]
12. Cita con resumen
Coulter DM, Bate A, Meyboom RHB, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ 2001;322:1207-9. [Ref.ID 56538]
Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RHB. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO International Database. Drug Saf 2000;23:533-42. [Ref.ID 54161]
14. Cita con resumen
Meyboom RHB, Lindquist M, Flygare AK, Biriell C, Edwards IR. The value of reporting therapeutic ineffectiveness as an adverse drug reaction. Drug Saf 2000;23:95-9. [Ref.ID 51906]
15. Cita con resumen
Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000;22:415-23. [Ref.ID 51340]
Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000;9:105-12. [Ref.ID 50426]
Lindquist M, Edwards IR, Bate A, Fucik H, Nunes A M. From association to alert - a revised approach to international signal analysis. Pharmacoepidemiol Drug Saf 1999;8:15-25. [Ref.ID 44324]
Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998;54:315-21. [Ref.ID 39267]
Lindquist M, Pettersson M, Edwards IR, Sanderson J, Taylor N, Fletcher P, Schou J, Fraunfelder FT. How does cystitis affect a comparative risk profile of tiaprofenic acid with other non-steroidal antiinflammatory drugs? An international study based on spontaneous reports and drug usage data. Pharmacol Toxicol 1997;80:211-7. [Ref.ID 38008]
Stahl MMS, Lindquist M, Pettersson M, Edwards IR, Sanderson JH, Taylor NFA, Fletcher AP, Schou JS. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol 1997;53:163-9. [Ref.ID 36583]
Seleccionar todas
 1 a 20 de 31 siguiente >>